Michael Lundquist Grant to Advance MSA-C Research

The Michael Lundquist Grant to Advance MSA-C Research is awarded annually by the National Ataxia Foundation to independent researchers for outstanding proposals that aim to make meaningful advancements in the treatment and care of individuals affected by multiple system atrophy, cerebellar subtype (MSA-C). While proposals may include aspects relevant to other forms of ataxia, the primary focus must be on preclinical, translational, or clinical research directly related to MSA-C. Priority is given to proposals that accelerate the development of disease-modifying therapies, support clinical trial readiness including biomarker discovery and validation, develop new or improve existing methods for accurate and timely diagnosis of MSA-C, bridge the gap between scientific discovery and therapeutic application, and significantly advance or reshape mechanistic understanding of MSA-C pathogenesis. This grant honors the legacy of Michael Lundquist and reflects NAF's commitment to advancing research that improves outcomes for people living with MSA-C.